A Dual Altered Peptide Ligand Down-Regulates Myasthenogenic T Cell Responses by Up-Regulating CD25- and CTLA-4-Expressing CD4+T Cells by Paas-Rozner, Miri, Sela, Michael, Mozes, Edna

The Nature of the Active Suppression of Responses Associated with Experimental Autoimmune Myasthenia Gravis by a Dual Altered Peptide Ligand Administered by Different Routes by Paas-Rozner, Miri, Sela, Michael, Mozes, Edna

Oral Administration of a Dual Analog of Two Myasthenogenic T Cell Epitopes down-Regulates Experimental Autoimmune Myasthenia Gravis in Mice by Paas-Rozner, Miri, Dayan, Molly, Paas, Yoav, Changeux, Jean-Pierre, Wirguin, Itzhak, Sela, Michael, Mozes, Edna

Altered Peptide Ligands Act as Partial Agonists by Inhibiting Phospholipase C Activity Induced by Myasthenogenic T Cell Epitopes by Faber-Elmann, Anat, Paas-Rozner, Miri, Sela, Michael, Mozes, Edna

A Peptide Composed of Tandem Analogs of Two Myasthenogenic T Cell Epitopes Interferes with Specific Autoimmune Responses by Katz-Levy, Yael, Paas-Rozner, Miri, Kirshner, Susan, Dayan, Molly, Zisman, Einat, Fridkin, Mati, Wirguin, Itzhak, Sela, Michael, Mozes, Edna

Peptide Analogs to Pathogenic Epitopes of the Human Acetylcholine Receptor α Subunit as Potential Modulators of Myasthenia Gravis by Zisman, Einat, Katz-Levy, Yael, Dayan, Molly, Kirshner, Susan L., Paas-Rozner, Miri, Karni, Arnon, Abramsky, Oded, Brautbar, Chaim, Fridkin, Mati, Sela, Michael, Mozes, Edna

A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses by Yael Katz-Levy, Miri Paas-Rozner, Susan Kirshner, Molly Dayan, Einat Zisman, Mati Fridkin, Itzhak Wirguin, Michael Sela, Edna Mozes